News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
174 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (25774)
Month
January (3339)
February (3294)
March (4068)
April (3458)
May (4782)
June (3455)
July (2690)
August (3589)
September (3334)
October (3977)
November (4082)
December (2500)
Day
1 (91)
2 (3)
3 (2)
4 (151)
5 (174)
6 (161)
7 (160)
8 (71)
9 (27)
10 (33)
11 (192)
12 (183)
13 (167)
14 (149)
15 (70)
16 (1)
17 (6)
18 (159)
19 (166)
20 (166)
21 (140)
22 (56)
23 (2)
24 (3)
25 (2)
26 (39)
27 (55)
28 (41)
29 (28)
30 (1)
31 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Drug Development
Alto’s Neuropsychiatric Platform Scores Third Mid-Stage Win
ALTO-300 was significantly more effective in major depressive disorder patients with a specific EEG biomarker than in those without, according to results from an Alto Neuroscience Phase IIa study.
December 5, 2023
·
2 min read
·
Tristan Manalac
Drug Development
Roche Gets Phase III Breast Cancer Victory for Inavolisib Combo
A combination of Roche’s investigational treatment with Ibrance and fulvestrant met its primary endpoint of progression-free survival in the first-line setting in treating PIK3CA-mutated breast cancer.
December 5, 2023
·
2 min read
·
Tyler Patchen
CRISPR Reorganizes CAR-T Pipeline Ahead of FDA’s Landmark Decision
The gene editing company is dropping two programs and favoring its next-generation assets CTX112 and CTX131, which it will continue to develop in oncology but will also test in autoimmune diseases.
December 5, 2023
·
2 min read
·
Tristan Manalac
Drug Development
Artificial Intelligence, Part 3: Improving Communication to Impact Patient Behavior
In this third episode of Denatured’s series on AI in drug discovery, we discuss patient behavior and its influence on clinical trials and AI models with guests from GSK, IQVIA, Exelixis and DataHow.
December 5, 2023
·
1 min read
·
BioSpace Insights
J&J Expects Up to 6% Growth Next Year with 20-Plus New Drugs by 2030
Ten of the anticipated assets have the potential to deliver $5 billion or more in peak year sales, while another 15 of the candidates have a $1 billion to $5 billion PYS potential, according to Johnson & Johnson.
December 5, 2023
·
2 min read
·
Kate Goodwin
Policy
FDA Puts Clinical Hold on Roche BTK Inhibitor Multiple Sclerosis Program
The regulator placed a partial clinical hold on Roche’s fenebrutinib—being developed for relapsing MS—after two patients experienced elevated hepatic transaminase and bilirubin levels indicative of liver injury.
December 5, 2023
·
2 min read
·
Tristan Manalac
Updated: Radiopharmaceuticals Market Predicted to Grow Rapidly Over Next Decade
Fueled partly by increasing lifespans and cancer incidence, the area’s worth is projected to soar to 13.67 billion by 2032, Precedence Research reports.
December 5, 2023
·
5 min read
·
Patience Asanga
Novadip Biosciences SA announces significant clinical milestones for both of its clinical-stage programs
Novadip Biosciences SA announced that the first US patient has been implanted with its investigational tissue regeneration product, NVD-003, in its Phase 1b/2a clinical trial in Congenital Pseudarthrosis of Tibia, a rare pediatric bone condition.
December 5, 2023
·
5 min read
Business
AQEMIA Announces a Major Multi-year Collaboration of $140 Million With Sanofi
AQEMIA, a pioneering pharmatech company leveraging AI and quantum-inspired physics to accelerate the discovery of small molecule drug candidates with higher probability of success in the clinic, announces a multi-year research collaboration with the global pharmaceutical company Sanofi.
December 5, 2023
·
3 min read
Biotech Bay
Translational Science Is the Key to the Success of the Clinical Research
In Q2 2023, Amador Bioscience, a next generation CRO focusing on translational science and early clinical development, announced the addition of Dr. Lorin Roskos to the Board of Directors.
December 5, 2023
·
11 min read
1 of 18
Next